Pure Global AI
NCT06376994Not yet recruiting

Multi-Center Clean Air Randomized Controlled Trial in COPD

JHSPH Center for Clinical TrialsPhase 3ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Chronic Obstructive Pulmonary Disease (COPD)
Drug/Device/Intervention
Air cleaner
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
JHSPH Center for Clinical Trials
Location
Baltimore, United States of America
Timeline & enrollment
Phase
Phase 3
Start date
Sep 01, 2024
End date
Sep 01, 2028
Enrollment
770 participants
Primary outcome

St. George's Respiratory Questionnaire (SGRQ)

Summary

This is a multi-center randomized, sham-controlled clinical trial to determine the
 effectiveness of an air cleaner intervention aimed at improving indoor air quality on
 reducing COPD exacerbation risk and improving quality of life, functional status, rescue
 medication use.

ICD-10 classifications
Other chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06376994
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06376994 through Pure Global AI's free database. This Phase 3 trial is sponsored by JHSPH Center for Clinical Trials and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease (COPD). Target enrollment is 770 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.